| abstract |
Disclosed is a oxazolidene-carboxyl acid derivative of general formula (I) wherein R1 and X have the meaning stated in description and their physiologically acceptable salts or solvates remit binding of fibrinogen to the corresponding receptor and therefore are usable for production of pharmaceutical copmositions, e. g. for treatment of blood clots, osteolytic diseases, tumour diseases, apoplexia, heart attack, sores and arteriosclerosis. Method of production of these derivatives and pharmaceutical compositions containing them. |